{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-26-000106","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2026-09-03T21:05:38+00:00","discovered_at":"2026-09-03T21:08:41.345282+00:00","generated_at":"2026-09-03T21:08:45.247123+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Immunovant annual meeting: directors elected, E&Y ratified, say-on-pay approved","bullets":["198,373,370 shares represented (~96% of eligible) at Sept 2, 2026 annual meeting.","Directors Bauer, Hughes, Susman elected with 162.9M, 174.1M, 181.6M votes for, respectively.","Ernst & Young ratified as independent auditor for FY ending March 31, 2027 (198.1M for).","Non-binding say-on-pay approved: 180.8M for, 8.4M against, 91.9K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-26-000106","json":"https://secwatch.observer/filing/0001764013-26-000106.json","markdown":"https://secwatch.observer/filing/0001764013-26-000106.md","text":"https://secwatch.observer/filing/0001764013-26-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/0001764013-26-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/imvt-20260902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-03T21:08:45.247123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}